Work

915P Longer OS and RFS for CD3high/PD-L1+ head and neck squamous cell carcinoma (HNSCC) patients

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.976

Authors: S. Laban, R. Remark, C. Idel, J. Ribbat-Idel, R. Krupar, A. Schröck, N. Klümper, J. Döscher, A.G. Sikora, T. Abou Kors, A. von Witzleben, J. Vahl, A. Grages, M. Sonntag, C. Brunner, T.K. Hoffmann, S. Gnjatic

Institutions: Universität Ulm, University Hospital Ulm, Innate Pharma (France), University Hospital Schleswig-Holstein, University of Lübeck, University Hospital Bonn, University Hospital Augsburg, The University of Texas MD Anderson Cancer Center, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402560817

FWCI: 0.391

Cites:

Cited by: 1

Related to: 10